These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
32. DARPins as bispecific receptor antagonists analyzed for immunoglobulin E receptor blockage. Eggel A; Baumann MJ; Amstutz P; Stadler BM; Vogel M J Mol Biol; 2009 Oct; 393(3):598-607. PubMed ID: 19683003 [TBL] [Abstract][Full Text] [Related]
33. Tethered-variable CL bispecific IgG: an antibody platform for rapid bispecific antibody screening. Kim HS; Dunshee DR; Yee A; Tong RK; Kim I; Farahi F; Hongo JA; Ernst JA; Sonoda J; Spiess C Protein Eng Des Sel; 2017 Sep; 30(9):627-637. PubMed ID: 28985411 [TBL] [Abstract][Full Text] [Related]
34. Stability engineering of scFvs for the development of bispecific and multivalent antibodies. Miller BR; Demarest SJ; Lugovskoy A; Huang F; Wu X; Snyder WB; Croner LJ; Wang N; Amatucci A; Michaelson JS; Glaser SM Protein Eng Des Sel; 2010 Jul; 23(7):549-57. PubMed ID: 20457695 [TBL] [Abstract][Full Text] [Related]
40. Understanding the role of cross-arm binding efficiency in the activity of monoclonal and multispecific therapeutic antibodies. Harms BD; Kearns JD; Iadevaia S; Lugovskoy AA Methods; 2014 Jan; 65(1):95-104. PubMed ID: 23872324 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]